ASC- and caspase-1-deficient C57BL/6 mice do not develop demyelinating disease after infection with Theiler's murine encephalomyelitis virus
- PMID: 37414913
- PMCID: PMC10326010
- DOI: 10.1038/s41598-023-38152-3
ASC- and caspase-1-deficient C57BL/6 mice do not develop demyelinating disease after infection with Theiler's murine encephalomyelitis virus
Abstract
Theiler's murine encephalomyelitis virus (TMEV) induces an acute polioencephalomyelitis and a chronic demyelinating leukomyelitis in SJL mice. C57BL/6 (B6) mice generally do not develop TMEV-induced demyelinating disease (TMEV-IDD) due to virus elimination. However, TMEV can persist in specific immunodeficient B6 mice such as IFNβ-/- mice and induce a demyelinating process. The proinflammatory cytokines IL-1β and IL-18 are activated by the inflammasome pathway, which consists of a pattern recognition receptor molecule sensing microbial pathogens, the adaptor molecule Apoptosis-associated speck-like protein containing a CARD (ASC), and the executioner caspase-1. To analyze the contribution of the inflammasome pathway to the resistance of B6 mice to TMEV-IDD, ASC- and caspase-1-deficient mice and wild type littermates were infected with TMEV and investigated using histology, immunohistochemistry, RT-qPCR, and Western Blot. Despite the antiviral activity of the inflammasome pathway, ASC- and caspase-1-deficient mice eliminated the virus and did not develop TMEV-IDD. Moreover, a similar IFNβ and cytokine gene expression was found in the brain of immunodeficient mice and their wild type littermates. Most importantly, Western Blot showed cleavage of IL-1β and IL-18 in all investigated mice. Consequently, inflammasome-dependent activation of IL-1β and IL-18 does not play a major role in the resistance of B6 mice to TMEV-IDD.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.Virology. 2000 Dec 20;278(2):346-60. doi: 10.1006/viro.2000.0646. Virology. 2000. PMID: 11118358
-
Interferon-stimulated genes-essential antiviral effectors implicated in resistance to Theiler's virus-induced demyelinating disease.J Neuroinflammation. 2015 Dec 24;12:242. doi: 10.1186/s12974-015-0462-x. J Neuroinflammation. 2015. PMID: 26703877 Free PMC article.
-
Inducible nitric oxide synthase in Theiler's murine encephalomyelitis virus infection.J Virol. 1997 Apr;71(4):3228-35. doi: 10.1128/JVI.71.4.3228-3235.1997. J Virol. 1997. PMID: 9060686 Free PMC article.
-
Excessive Innate Immunity Steers Pathogenic Adaptive Immunity in the Development of Theiler's Virus-Induced Demyelinating Disease.Int J Mol Sci. 2021 May 17;22(10):5254. doi: 10.3390/ijms22105254. Int J Mol Sci. 2021. PMID: 34067536 Free PMC article. Review.
-
Critical role of TLR activation in viral replication, persistence, and pathogenicity of Theiler's virus.Front Immunol. 2023 Apr 20;14:1167972. doi: 10.3389/fimmu.2023.1167972. eCollection 2023. Front Immunol. 2023. PMID: 37153539 Free PMC article. Review.
Cited by
-
A multiantigenic Orf virus-based vaccine efficiently protects hamsters and nonhuman primates against SARS-CoV-2.NPJ Vaccines. 2024 Oct 16;9(1):191. doi: 10.1038/s41541-024-00981-2. NPJ Vaccines. 2024. PMID: 39414789 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous